FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072175 [Registered on: 08/08/2024] Trial Registered Prospectively
Last Modified On: 31/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [therapy]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Nasya and Tarpana in dry eye syndrome 
Scientific Title of Study   A Randomised Comparative Clinical Trial To Evaluate The Efficacy Of Jeevaniya Ghrita Nasya In Comparison To Jeevaniya Ghrita Tarpana In Shushakakshipaka W.S.R. Dry Eye Syndrome 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kamlesh kumari 
Designation  pg scholar 
Affiliation  National Institute of Ayurveda Jaipur 
Address  Department of shalakya tantra National institute of ayurveda jorawar singh gate jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  9667249809  
Fax    
Email  olakamleshkumari0613@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aparna sharma 
Designation  Associate professor 
Affiliation  National Institute of Ayurveda Jaipur 
Address  room no.312 Department of shalakya tantra National institute of ayurveda jorawar singh gate jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  8955688129  
Fax    
Email  appu07@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kamlesh kumari 
Designation  pg sholar 
Affiliation  National institute of Ayurveda Jaipur 
Address  Department of shalakya tantra National institute of ayurveda jorawar singh gate jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  9667249809  
Fax    
Email  olakamleshkumari0613@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda, Jaipur 302002 
 
Primary Sponsor  
Name  National institute of Ayurveda Jaipur 
Address  Department of Shalakya Tantra National institute of Ayurveda jorawar singh gate jaipur 302002 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kamlesh Kumari  National institute of Ayurveda, Hospital, OPD no.14  Jorawar singh gate, amer road jaipur, rajasthan, 302002 Department of Shalakya Tantra Opd 14
Jaipur
RAJASTHAN 
9667249809

olakamleshkumari0613@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
InstitutionalEthicsCommittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H041||Other disorders of lacrimal gland. Ayurveda Condition: SUSHKAKSHIPAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: JeevaniyaGhrita, Reference: Shusrut samhita Uttar tantra chapter no.9, Shloka no.21, Route: Topical, Dosage Form: Ghrita, Dose: 6(drops), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: 2 sittings of 7 days with 7days of gap in between.
2Comparator ArmDrugClassical(1) Medicine Name: JeevaniyaGhrita, Reference: Shusrut samhita Uttar tantra chapter no.9, Shloka no.21, Route: Topical, Dosage Form: Ghrita, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -tarpana procedure will be done as per classical method.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients presenting with signs and symptoms such asRukshta,Gharshana, Avildarshanam,Daha, etcandwith atleast 2 positive diagnostic test. 
 
ExclusionCriteria 
Details  1. Patient with impaired eyelid function as in bell’s palsy.
2. Nocturnal legophthalmos.
3. Patient having pterygium, ectropion, corneal ulcer, glaucoma, inflammatory condition like acute conjunctivitis / keratitis.
4. Patient with rheumatoid arthritis and sjogrens syndrome.
5. patients suffering from infective ocular surface pathology.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Tear film break up time will be assesed before and after the intervention to see the improvement with the help of shimmers strip.   0th, 21st and 30th day 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in overall rating of subjective ocular symptoms.  0th, 21st and 30th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   two procedures in parallel groups one group intervention procedure is nasa with jeevaniya ghrita other group intervention is tarpana procedure 
Close